These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8388497)

  • 21. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.
    Smythe JA; Sun D; Thomson M; Markham PD; Reitz MS; Gallo RC; Lisziewicz J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3657-61. PubMed ID: 8170964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine retroviral vectors expressing the tax1 gene of human T-cell leukemia virus type 1.
    Akagi T; Nyunoya H; Shimotohno K
    Gene; 1991 Oct; 106(2):255-9. PubMed ID: 1937053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors.
    Bovia F; Salmon P; Matthes T; Kvell K; Nguyen TH; Werner-Favre C; Barnet M; Nagy M; Leuba F; Arrighi JF; Piguet V; Trono D; Zubler RH
    Blood; 2003 Mar; 101(5):1727-33. PubMed ID: 12406892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
    Zhou C; Bahner I; Rossi JJ; Kohn DB
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A third-generation lentivirus vector with a conditional packaging system.
    Dull T; Zufferey R; Kelly M; Mandel RJ; Nguyen M; Trono D; Naldini L
    J Virol; 1998 Nov; 72(11):8463-71. PubMed ID: 9765382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.
    Veres G; Junker U; Baker J; Barske C; Kalfoglou C; Ilves H; Escaich S; Kaneshima H; Böhnlein E
    J Virol; 1998 Mar; 72(3):1894-901. PubMed ID: 9499041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.
    Liu J; Woffendin C; Yang ZY; Nabel GJ
    Gene Ther; 1994 Jan; 1(1):32-7. PubMed ID: 7584057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy.
    Furuta RA; Kubota S; Maki M; Miyazaki Y; Hattori T; Hatanaka M
    J Virol; 1995 Mar; 69(3):1591-9. PubMed ID: 7853493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of simian immunodeficiency virus replication by human immunodeficiency virus type 1 trans-dominant negative rev mutants.
    Endres CL; Bergquam EP; Axthelm MK; Wong SW
    J Virol; 1995 Aug; 69(8):5164-6. PubMed ID: 7609088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene.
    Ranga U; Woffendin C; Yang ZY; Xu L; Verma S; Littman DR; Nabel GJ
    J Virol; 1997 Sep; 71(9):7020-9. PubMed ID: 9261432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.
    Woffendin C; Yang ZY; Udaykumar ; Xu L; Yang NS; Sheehy MJ; Nabel GJ
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11581-5. PubMed ID: 7972106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
    Ulich C; Harrich D; Estes P; Gaynor RB
    J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme.
    Weerasinghe M; Liem SE; Asad S; Read SE; Joshi S
    J Virol; 1991 Oct; 65(10):5531-4. PubMed ID: 1895402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.
    Kotsopoulou E; Kim VN; Kingsman AJ; Kingsman SM; Mitrophanous KA
    J Virol; 2000 May; 74(10):4839-52. PubMed ID: 10775623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.
    Sun LQ; Pyati J; Smythe J; Wang L; Macpherson J; Gerlach W; Symonds G
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7272-6. PubMed ID: 7638180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.